In our study, GCs were able to limit CXCL8 mRNA, protein in cell lysates, as well as protein secretion into culture media, supporting our hypothesis that GCs could be protective in AH and sepsis if nonhepatic side effects can be limited. The gene discussed is CXCL8; the disease is Sepsis.